A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms

Exclusion Criteria

• •Concurrent hot flash therapies (prescription medications including hormone replacement therapies, gabapentin or over the counter supplements), vaginal hormonal products (rings, creams, gels) or transdermal estrogen or estrogen/progestin products for 30 days before screening visit.
• •Women currently or previously on anticoagulants, Vitamin K antagonists like warfarin in the past 3 months, or expected to be on anticoagulants in the near future.
• •Women involved in other clinical studies within the last 30 days.
• •Any women who, in the opinion of the principal investigator, is at poor medical or psychiatric risk for the study.